For example, reduced levels of miR-29c have been shown to de-repress expression of MCL-1 and TCL-1, known oncogenes implicated in the CLL anti-apoptotic defect [30], [31], [33]. Here, MCL1 is linked to B-cell chronic lymphocytic leukemia.